FDA approves Gilead's once-daily combination pill for suppressed HIV patients
The US Food and Drug Administration has approved Gilead Sciences' (GILD) Bixlenvo, a once-daily oral combination pill for adults whose HIV infection has already been suppressed to very low levels, the company said.